Stable ΔN-IκBα Expressing HOS-G (HOS-G/ΔN-IκBα) Cell Line

Unit

1×10⁶ cells / 1 ml

Cell Type

Stable (KO/Expressing) Cells

Tissue Type

Bone

Organism

Human (H. sapiens)

Donor History
Growth Properties

Adherent

,

bipolar

Growth Conditions

PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. Dulbecco's Modified Eagle Medium (DMEM)

,

High Glucose (TM500) + 10% FBS + 2 mM L-Glutamine (G275) + 1% Penicillin/Streptomycin Solution (G255)

,

37.0°C

,

5% CO₂.

Immortalization Method
Full Information

https://www.abmgood.com/stable-delta-n-i-kappab-alpha-expressing-hos-g-cell-line-hos-g-delta-n-i-kappab-alpha.html

Katalogové číslo: T6108 Kategorie: ,
Popis

Human Osteosarcoma (HOS) cells were transfected with a Lentivirus vector to stably express a degradation resistant I-κBα (δN-I-κBα) under the control of a SV40 promoter. Successfully transfected cells were selected for puromycin resistance. As a result of the constitutive repression of NF-κB by the degradation resistant inhibitor δN-I-κBα, these cells are resistant to senescence caused by infection with human T-lymphotropic virus type 1 (HTLV-1). HOS-G/ΔN-IκBα line can be productively infected by HTLV-1 as it contains a reporter cassette consisting of 18 copies of Tax-inducible HTLV-1 21bp repeat, the HTLV-1 TATA element, the complete R region, and part of the U5 sequence fused with enhanced green fluorescence protein (eGFP). As a result of this reporter element the expression of eGFP is a positive indicator of successful HTLV-1 infection in cells. It is suggested that this cell line can be used to study of HTLV-1 replication in cell culture.

O značce
Applied Biological Materials (abm) je jedním z našich klíčových dodavatelů pro biotechnologický průmysl. Společnost byla založena v roce 2004 a již více než deset let podporuje vědecké objevy v oblasti přírodních věd a vývoje léčiv. Její sídlo se nachází ve Vancouveru v Kanadě. ABM je pro nás neocenitelným partnerem zejména v  oblasti dodávek buněčných kultur, genových a virových vektorů, produktů pro molekulární biologii a PCR, nástrojů pro technologie CRISPR a RNAi, protilátek i základních reagencií pro molekulárně genetické procesy.